Gunnar Järnerot
About
In The Last Decade
Gunnar Järnerot
126 papers receiving 8.9k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Genetics 5.4k
- Epidemiology 5.0k
- Surgery 2.9k
- Molecular Biology 1.8k
- Gastroenterology 1.2k
Countries citing papers authored by Gunnar Järnerot
This map shows the geographic impact of Gunnar Järnerot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gunnar Järnerot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gunnar Järnerot more than expected).
Fields of papers citing papers by Gunnar Järnerot
This network shows the impact of papers produced by Gunnar Järnerot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gunnar Järnerot. The network helps show where Gunnar Järnerot may publish in the future.
Co-authorship network of co-authors of Gunnar Järnerot
This figure shows the co-authorship network connecting the top 25 collaborators of Gunnar Järnerot. A scholar is included among the top collaborators of Gunnar Järnerot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gunnar Järnerot. Gunnar Järnerot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis breakdown → | 701 |
| 3 | Colectomy after rescue therapy for intravenous-steroid resistant acute ulcerative colitis : a 3-year follow-up study of the Swedish-Danish infliximab/placebo trial | 4 |
| 4 | 55 | |
| 5 | Decreasing pair concordance in monozygotic twins with Crohn's disease | 7 |
| 6 | 46 | |
| 7 | 156 | |
| 8 | 11 | |
| 9 | CA 19-9, CA50 and CA242 as tools for diagnosis of cholangiocarcinoma (CC) in patients with primary sclerosing cholangitis (PSC). | 4 |
| 10 | 3 | |
| 11 | 55 | |
| 12 | 38 | |
| 13 | 120 | |
| 14 | 69 | |
| 15 | 33 | |
| 16 | 21 | |
| 17 | 37 | |
| 18 | 50 | |
| 19 | The thyroid in ulcreative colitis and Crohn's disease. III. The daily fractional turnover of thyroxine. | 5 |
| 20 | [Iodine deficiency--still a reality?]. | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.